chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pain and swelling began ~ 1 hour after dose at injection site, enlarged by evening to rest of upper arm, arm pit, shoulder and neck, still exists as of 5/13 at 2:30 pm although subsided some  Fever and chills started 5/10, ~ 9 pm, ~10 hours after dose, lasting ~2 days.  Next day 5/11, headache, constipation, dark urine, lasting ~2 days. Congestion and mild cough started ~2 days after.  Treatment consisted of advil, benadryl, and sudafed.
Information has been received from a registered nurse concerning a 15 month old male with no known history or allergies who on 08-May-2006 was vaccinated with a 0.5 ml SC dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (+) varicella virus vaccine live (lot#651815/0950R). There was no concomitant medication.  On 18-Aug-2006 the patient developed a fever of 99.7 F and about 50 lesions on the sides of his trunk.  He was seen in the office for breakthrough varicella.  Medical attention was sought.  No treatment was reported.  At the time of the report the patient had not recovered.  No product quality complaint was involved.  Additional information has been requested.
Swelling and tenderness/warmth (8x8cm) about 2 inches below injection site Lt deltoid.
Narrative:  Patient reports in October 2021 that since their receipt of their first dose of Moderna COVID vaccine, they have experienced intermittent dizziness and fatigue. They describe the dizziness as "lightheadedness" and it does not appear to be associated with specific triggering factors (i.e. positional changes, etc.). Patient has had PT and Neurology consults placed, thus far additional testing/imaging has not revealed an origin of the lightheadedness.
Pt. c/o feeling SOB in nasal passage et c/o red area over injection site.
Patient didn't have an adverse reaction after her vaccine. Patient received a 5-11 COVID-19 vaccine instead of 12+ COVID-19 vaccine.
Soreness in neck muscles on the left side.; Feeling hot then cold; Cant get comfortable; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on an unknown date in Sep2021 at 09:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. It was unknown if the patient had allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included paracetamol (TYLENOL) from unknown date for unspecified indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Sep2021 at 09:00, the patient experienced soreness in neck muscles on the left side. She had a feeling of hot then cold and couldn't get comfortable. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events, soreness in neck muscles on the left side and had a feeling of hot then cold, couldn't get comfortable was not resolved at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
mom called & said pt ran a temp of 103 for 3-4 days p/vax on 13JUN95; was seen by MD also was whining during this period;
Patient received a 3rd dose of Moderna. 1st dose on 1/25/21, 2nd dose on 4/12/21, and 3rd dose on 6/17/21.
12/08/2022, Pfizer Pediatric Monovalent vaccine (2nd dose) was not diluted prior to administering. Client received 0.2 ml of undiluted vaccine. RN manager discovered the error on 12/15/2022. RN Manager called patient?s mother to report administration error. Mother stated the patient responded similarly as he did with the first dose. He had a low grade fever. No other symptoms were reported. Child was symptom-free when RN Manger spoke with patient?s mother.
sweating and racing heart noted on 09May21 Diagnosis of hyperthyroidism on 18Jun21
Two weeks after my second injection,  I experienced  extremely tender, very enlarged breasts (both breasts), and sharp shooting pains as well.  I equate the swelling and discomfort to the same feeling I had when pregnant or nursing.  Then on Sunday,  April 18th, the tenderness  started in my left  armpit.  I am  currently still experiencing these symptoms.  I had a normal  mammogram  last  June and  I do not feel  any lumps or nodules.
Initial report received from a nurse on 20 November 2013. A adult female patient whose medical history and concomitant medications were not reported, received FLUZONE ID (Lot # UT4722AA and expiration date 10-Apr-2014; Lot # UT4721AA and expiration date 08-Apr-2014) at deltoid. The patient had experienced redness, warmth, and discomfort with touch, swollen to 1/2 inch. This patient was injected near her old smallpox scar that she received as a child. The patient was recovered at the time of this report. List of documents held by sender: none.
On 02/15/2021 I had a rash on my arms and legs, I had itchy bumps all over my arms and leg. I called my doctor and was prescribed Medrol pack. The rash lasted a week and was gone.
Initial shot tenderness x3 days. No big deal  Day 11... site warm to touch, red rash, raised rash. Diameter Size of golfball . Moderate itching.  Diarrhea began on day 11.. not sure initially if related. Rash etc lasted 11 days.   Diarrhea too. Both went away at 11 days post secondary reaction.  No other concern after
This case was reported by a consumer via call center representative and described the occurrence of greenish stool in a female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 2nd dose of SHINGRIX. On an unknown date, 3 days after receiving SHINGRIX, the patient experienced greenish stool. On an unknown date, the outcome of the greenish stool was unknown. It was unknown if the reporter considered the greenish stool to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. After getting the 2nd shot of SHINGRIX, the patient's bowel moment was green. The patient received the shot of SHINGRIX on Thursday and on Sunday bowel moment was green. The patient was asking should they worry. The patient was stating that none of GSK information stated that this might happen.
tested positive; tested positive; extreme vertigo; threw up five times like a fire hydrant; exhausted; nauseous; headache; nervous; uncomfortable; This is a spontaneous report from a contactable consumer via medical information team. This 54-year-old female consumer (patient) reported for herself.  A 54-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID -19 VACCINE, solution for injection, Lot Number: not reported, Expiry date: unknown) via an unspecified route of administration, on an unspecified date as dose 1, single for COVID-19 immunization. Medical history included little overweight and doesn't drink or smoke or do drugs. The patient's concomitant medications were not reported. It was reported that on an unspecified date in 2021, patient experienced multiple adverse events after receiving the first dose of the Pfizer BioNTech Covid-19 Vaccine. She had extreme vertigo, threw up five times like a fire hydrant and once it was done, exhausted, nauseous, headache, nervous and uncomfortable. The reporter stated that she experienced multiple adverse events after receiving the first dose of the Pfizer BioNTech Covid-19 Vaccine. She stated that she had "extreme vertigo, threw up five times like a fire hydrant, and once it was done, exhausted, nauseous, and had a headache." The reporter stated she almost called 911. The reporter stated she is "pretty healthy, a little overweight, but doesn't drink or smoke or do drugs." The reporter stated that she went through Covid-19 and tested positive a month before, and then tested negative on 11Sep2021. The reporter stated that she did not receive monoclonal antibody treatment. She also stated that she feels nervous and uncomfortable about getting the second dose, and wants to find out how to get an exemption from the second dose. Patient did not receive monoclonal antibody treatment. The patient not received treatment for covid-19. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on an unspecified date on 2021, sars-cov-2 test: negative on 11Sep2021. The outcome of the events covid-19 was recovered on 11Sep2021 and other events were not recovered.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Patient complains of feeling "hot" after the vaccine and felt the feeling on her face. She said it felt like she had fibers on her face and then tiny bumps appeared on 2/12/22 that are still there today. She says that her blood pressure has been high since receiving the vaccine and she does not have a history of high blood pressure.
Pt has 1cm fatty necrosis noted to (R) thigh. Mom reported to Dr. at this visit pt had an induration with a few small red bumps around site a few days after the injection was given. No treatment or visit was done since vaccination given. No report of reaction til this visit.
Patient called 6/28/2010 describing sx's of a possible reaction to ZOSTAVAX. Patient has local site reaction - pain, redness, lump at site and now she has 3 "chicken pox" like pimples on 3 different areas of body. Instructed patient to keep an eye on and follow-up w/Dr. or pharmacy.
Flu like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Patient became non responsive, sweaty, glance look and decreased bp. did not faint. took approximately 2 minutes and last 4-5 minutes.
approx 8-12min p/vax pt started appearing pale, holding throat like going to vomit;got weak, limp, HR, dec 100 resp dec;adrenaline given, DPH & Decadron given;02;adm to hosp p/stable for observation;
Patient was given Kinrix.  Patient was not of correct age for that particular vaccine at the time of appointment.
Severe body aches, tired, fatigue, want to sleep, no energy, warm lips, nausea, no appetite. Took Tylenol 1 tblet-500 mg, PO, with a very mild relief. Will be taking 2 Tylenol's next.
Initial information was received from a medical assistant concerning a 5 months old patient, who on an unspecified date, the patient was vaccinated with a dose of PNEUMOVAX23 (dose, route, indication and lot, expiration date were not reported). No other co-suspects were reported. No concomitant medications were reported. No adverse effect was reported. No treatment information was reported. Additional information has been requested.
pt recv vax; c/o sharp pains; denies pain since 13nov; used ibuprofen;
Patient received vaccine that was stored improperly. Vaccine was moved from ultra-cold freezer to freezer on 06/17/2021. According to guidance from Pfizer, vaccine stored in the freezer after day 17 is considered improperly stored, and the patient will need to be re-vaccinated.
Pt completed vaccination series for the COVID-19 Pfizer, with one dose received 4/6/2021 and the 2nd received 4/27/2021.  Pt was seen at ED on 6/26/2021 for mental health related reasons, and tested positive for COVID-19 as part of routine admission screening.  Medical notes indicate the patient was asymptomatic for COVID-19.
Patient's grandmother contacted facility via phone call on 3/19/19 to inform of unusual symptoms which occurred approximately 5 minutes after patient received vaccinations on 3/12/19. She stated that the patient was sitting in his car seat when she noticed a reddened rash on his left cheek 1.5 inches in diameter. He then had 3 consecutive twitching episodes, lasting approximately 1 minute each. Patient was alert and oriented after the twitching episodes ended, and ate and drank appropriately. Red rash on left cheek disappeared after twitching episodes ended. Grandmother stated patient has had no further issues since then, and will make a follow-up appointment with the patient's pediatrician for further evaluation.
After both vaccines I had the typical fatigue, headache and sore arm.  But, I also experienced painful breasts and heart palpitations after both vaccines.  I'm still experiencing heart inflammation, high blood pressure (which I didn't have previously) and it's past 2 weeks after my 2nd shot.
Pt recvd vax 10JUL92 & 11JUL92 exp itching; presented to ER 26JUL92 & on 3AU92 seen by dermatologist w/generalized hives & inc histamine release (dermatographism); treated w/Seldane for allerg react;
Patient reported feeling like everything went black for a moment and began shaking  and dropped phone(described as seizure like) about 1 minute after receiving vaccine.  Technician alerted pharmacist to patient not looking well, patient was sweaty and confused/breathing heavy but able to speak clearly.  Blood pressure was measured at 109/75 pulse 72. No signs of anaphylactic reaction.  Patient was given water and BP monitored until family member arrived.
Bell's palsy, still has it, 2 months; This case was reported by a consumer via interactive digital media and described the occurrence of bell's palsy in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced bell's palsy (serious criteria GSK medically significant). On an unknown date, the outcome of the bell's palsy was not recovered/not resolved.   It was unknown if the reporter considered the bell's palsy to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by patient's friend. The age at vaccination was not reported. The reporter's friend got his 1st one and ended up with bell's palsy and still had it, about 2 months now. It did not seem to want to leave. The reporter asked that what did that tell you. The follow-up could not be possible as no contact details were available.
nurse administered a dose of expired Fluzone High Dose QIV to the patient with no reported adverse event; Initial information received on 11-Sep-2023 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 71 years old female patient whom nurse administered a dose of expired influenza quadrival A-B high dose HV vaccine [Fluzone High-Dose Quadrivalent] to the patient with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 11-Sep-2023, the patient received a dose 0.7 ml of suspect Influenza Quadrival A-B High Dose HV Vaccine formulation, strength: not reported lot UJ924AB via unknown route in unknown administration site for Immunization.  On 11-SEP-2023 nurse administered a dose of expired fluzone high dose qiv to the patient with no reported adverse event (expired product administered) on the same day following the administration of Influenza Quadrival A-B High Dose HV Vaccine.  Action taken was not applicable.  Reportedly, Today, a nurse administered a dose of expired Fluzone High Dose QIV to the patient (last year's formula). The injection site information was not available at the time of the call due to the nurse who administered the dose was with another patient. The patient received no other vaccines today.  At time of reporting, the outcome was Unknown for the event nurse administered a dose of expired fluzone high dose qiv to the patient with no reported adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Mom brought child for PPD reading and mentioned redness in right deltoid, no swelling, not warm. No symptoms. Child had received MMRV on right arm.
I was diagnosed with tinnitus in 08/2021 and I noticed the issue in 05/2021. It got really bad in July. There was constant ringing in both of my ears and it didn't stop. I had trouble sleeping. I went to my doctor and she sent me to an ENT specialist. They gave me a hearing test and I had my blood drawn. They determined that the vaccine may have caused it. They said that many people have experienced a similar problem with ringing in the ears. The doctor told me that the problem might resolve later, but they were unsure. In 09/2021, I experienced a sharp pain in my lower left side. I went to my primary care physician. I was sent to an outpatient clinic to get a CT scan. I then went to the ER. I was diagnosed with diverticulitis. I was sent home later that night. I was given Augmentin to fight the infection. I now have dietary restrictions. I can't eat anything like corn or anything that has seeds in it because an infection could occur.
nervous; experienced numbness in their shoulder, neck and jaw; This is a spontaneous report from a contactable consumer or other non hcp (patient herself). A 46-years-old female patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Lot number was not reported, Expiry date: Unknown) via an unspecified route of administration on 26May2021 as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced nervous, and numbness in their shoulder, neck and jaw. It took 5 hours to go away. The seriousness of the events was non-serious. The outcome of the events was recovered.  Information about lot/ batch number can be requested.
deathly ill (the flu); deathly ill (the flu); Initial information was received on 13-Nov-2020 regarding an unsolicited valid serious case from a consumer or non-health care professional.  This case involves a patient in late 70's (age unspecified) who got deathly ill (the flu) (influenza) (Illness), while patient received INFLUENZA VACCINE.  Medical history, medical treatment, vaccination, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) [lot number and expiry date not reported] via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient got deathly ill (the flu) (influenza) (Illness) (unknown latency) following the administration of INFLUENZA VACCINE. These events were assessed as medically significant.  Details of laboratory data not reported.  It was not reported if the patient received any corrective treatment.  At the time of report, the outcome of events were unknown.  There will be no information available on lot number.; Sender's Comments: This case concerns an elderly patient (late 70's) (exact age unspecified) who got deathly ill with flu after vaccination with INFLUENZA VACCINE. The time to onset is unknown with the role of the vaccine. Additional information regarding patient's medical history, condition at the time of vaccination, lab data excluding predisposing etiologies would be needed for complete assessment of the case. Based upon the reported information, the role of the vaccine cannot be assessed.
She noted some itching in her L breast in August and then a rapidly growing mass. She had received some clindamycin for dental infection in August. She was seen by GYN on 10/19/2021 and sent for diagnostic mammogram and u/s.. Studies done 10/25 noted a 4cm mass from 6-9:00 in the L breast read as BIRADS 4. Sent for Biopsy at a local Radiology office.
Fever, crying, diaper rashes, edema at site of vaccination. Yeast infection including oral thrush, speech delay and regression. Decreased muscle tone, delayed motor skills, repetitive behavoirs, sensory issues including high pain tolerance. Diagnosed with PDD.
STAGE 1 BREAST CANCER; This spontaneous report received from a patient concerned a 59 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 206A21A, and expiry: 18-FEB-2022) dose was not reported, 1 total administered to left arm on 07-APR-2021 for prophylactic vaccination. Age at time of vaccination 58 years old. No concomitant medications were reported. On 01-APR-2022, the patient was diagnosed with stage 1 breast cancer. On APR-2022, after magnetic resonance imaging (MRI), three lesions on right breast were present and that had not been biopsied at the time of reporting. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from stage 1 breast cancer. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20220434355-COVID-19 VACCINE AD26.COV2.S  Stage 1 breast cancer. The event(s) shows an incompatible temporal relationship. Therefore, this event(s) is considered not related.
Observed by parents. Pt. eyes rolled up and she slumped over on exam table. Parents observed a 5 second tonic clonic upper extremity seizure. Pt. awoke, was pale. Pulse oximetry 99. BP: 90/60. I examined pt after episode. She remained stable. I explained syncopal episode with stress and that rarely is this even a seizure disorder. Parents aware to call with any concerns.